Speech-Language Pathologists in N Bethesda, MD Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Lauren Michelle Polovoy, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11908 Bristol Manor Ct, N Bethesda, MD 20852 Phone: 301-881-1394 |
Beryl Herda, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11908 Bristol Manor Ct, N Bethesda, MD 20852 Phone: 301-881-1394 |
Pamela Braunstein, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11908 Bristol Manor Ct, N Bethesda, MD 20852 Phone: 301-943-0920 |
Emily Genovese, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11908 Bristol Manor Ct, N Bethesda, MD 20852 Phone: 301-881-1394 |
Hallie Bulkin, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11908 Bristol Manor Ct, N Bethesda, MD 20852 Phone: 301-943-0920 Fax: 240-206-3250 |
News Archive
Implantable sensor technology and cartilage scaffolding systems for bone and joint repair
A group of biomedical engineering researchers have cited recent advances in implantable sensor technology and cartilage scaffolding systems as major developments in the use of engineered cartilage for bone and joint repair.
Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.
Existing sleep deprivation theory challenged
What goes on in your brain when you're sleep deprived and how does it affect your ability to process information and make decisions?
Exact Sciences completes underwritten public offering of common stock
Exact Sciences Corp. today announced that it has completed its previously announced underwritten public offering of its common stock at a price of $8.00 per share to the public.
Inaugural meeting of the International Specialty Orthopaedic Collaboratorium
Nine institutions from eight countries participated in the inaugural meeting of the International Specialty Orthopaedic Collaboratorium (ISOC), hosted by New York City's Hospital for Special Surgery.
› Verified 5 days ago